Longitudinal Antimalarial Combinations in Uganda

NCT00123552 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

601

Enrollment

OTHER

Sponsor class

Conditions

Malaria

Interventions

DRUG: Amodiaquine+Artesunate
DRUG: Amodiaquine+Sulfadoxine/Pyrimethamine
DRUG: Artemether+Lumefantrine

Sponsor

University of California, San Francisco

Collaborators

[object Object]